Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78/PERK/eIF2α pathway, and improves cardiac injury by suppressing TLR4/NF-κB inflammatory pathway
Cited by 8
Related Papers
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
|Advanced Science|2022|73
Components, mechanisms and applications of stimuli-responsive polymer gels
|European Polymer Journal|2022|67
Clinical Characteristics and Outcomes of Community-Acquired versus Hospital-Acquired Acute Kidney Injury: A Meta-Analysis
|Kidney & Blood Pressure Research|2019|40